In this context, our analysis of immune infiltration in CRC showed a higher increase in the NK activation marker NKP46, the most specific marker to detect NK cells, in MSI stage II tumours with reduced HLA-A. This evidence concerns the gene HLA-A and colorectal carcinoma.